Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Vasopressin and Vasopressin Receptor Expression in the Arteries and Veins of Ovarian Neoplasms

NCT00160472 is registered in ClinicalTrials.gov with United States Department of Defense as lead sponsor.

NCT NCT00160472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00160472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Vasopressin and Vasopressin Receptor Expression in the Arteries and Veins of Ovarian Neoplasms
Lead sponsor
United States Department of Defense
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2004
Completion date
January 31, 2009
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian neoplasms